Immunovant, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
3.91
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
4
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.39
|
-0.41
|
-0.02
|
-5.13%
|
|
2022-06-30
|
-0.40
|
-0.35
|
0.05
|
12.50%
|
|
2022-03-31
|
-0.38
|
-0.41
|
-0.03
|
-7.89%
|
|
2021-12-31
|
-0.33
|
-0.36
|
-0.03
|
-9.09%
|
|
2021-09-30
|
-0.28
|
-0.35
|
-0.07
|
-25.00%
|
|
2021-06-30
|
-0.31
|
-0.31
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.33
|
-0.29
|
0.04
|
12.12%
|
|
2020-12-31
|
-0.26
|
-0.32
|
-0.06
|
-23.08%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.76
|
|
2022-03-31
|
-1.43
|
|
2021-03-31
|
-1.24
|
|
2020-03-31
|
-0.90
|
|
2019-03-31
|
0.00
|